ViGeneron GmbH, a gene therapy company, announced a research collaboration to utilize its novel engineered adeno-associated virus (vgAAV)...
For Investors
Don't miss the unique chance to join our journey. Become an investor and be the missing part of the first independent Blockchain B2B platform for Germany - BRICS.